¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"radiant energy absorption"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • absorption oil
    Èí¼öÀ¯
  • absorption spectrum
    Èí¼ö½ºÆåÆ®·³
  • absorption test
    Èí¼ö½ÃÇè, Èí¼ö°Ë»ç
  • cross absorption
    ±³Â÷Èí¼ö
  • fluorescent treponemal antibody absorption test
    Çü±¤¸Åµ¶Ç×üÈí¼ö°Ë»ç
  • hemoglobin absorption curve
    Çì¸ð±Û·ÎºóÈí¼ö°î¼±
  • infrared absorption method
    Àû¿Ü¼±Èí¼ö¹ý
  • internal absorption
    ³»ºÎÈí¼ö
  • moisture absorption
    Èí½À
  • maximum absorption
    ÃÖ´ëÈí¼ö
  • photoelectric absorption
    ±¤ÀüÈí¼ö
  • photon absorption
    ±¤ÀÚÈí¼ö
  • percutaneous absorption
    ÇǺΰæÀ¯Èí¼ö, °æÇÇÈí¼ö
  • sound absorption
    ¼Ò¸®Èí¼ö
  • specific absorption rate
    ºñÈí¼öÀ²
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • water absorption
    ¼öºÐÈí¼ö
  • binding energy
    °áÇÕ¿¡³ÊÁö
  • energy-rich bond
    (¢¡high energy bond) °í¿¡³ÊÁö°áÇÕ
  • high energy bond
    °í¿¡³ÊÁö°áÇÕ
  • circle absorption system
    ¼øÈ¯Èí¼ö½Äȸ·Î
  • energy transfer coefficient
    ¿¡³ÊÁöÀüÀ̰è¼ö
  • hemoglobin absorption curve
    Ç÷»ö¼ÒÈí¼ö°î¼±
  • mass energy transfer coefficient
    Áú·®¿¡³ÊÁöÀüÀ̰è¼ö
  • energy flux density
    ¿¡³ÊÁö¼Ó¹Ðµµ
  • total potential energy difference
    ÃÑÀ§Ä¡¿¡³ÊÁöÂ÷
  • energy
    ¿¡³ÊÁö
  • electronic energy level
    ÀüÀÚ¿¡³ÊÁö¼öÁØ
  • energy quantum
    ¿¡³ÊÁö¾çÀÚ
  • energy spectrum
    ¿¡³ÊÁö½ºÆåÆ®·³
  • energy fluence rate
    ¿¡³ÊÁöÇ÷ç¾ð½ºÀ², ¿¡³ÊÁö¿µÇâ·ü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 14 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • absorption line
    Èí¼ö¼±.
  • absorption oil
    Èí¼öÀ¯(ýåâ¥êú).
  • absorption site
    Èí¼öÁ¡
  • absorption test
    Èí¼ö½ÃÇè
  • absorption test, agglutinin
    ÀÀÁý¼Ò Èí¼ö½ÃÇè
  • absorption, cross
    ±³Â÷Èí¼ö½ÃÇè
  • antibody absorption
    Ç×üÈíÂø
  • antibody absorption test
    Ç×üÈí¼ö½ÃÇè(ù÷ô÷ýåâ¥ãËúÐ).
  • heat absorption
    ¿­Èí¼ö(æðýåâ¥).
  • index of absorption
    ÈíÂøÁö¼ö(̷̤̤Ëà).
  • index of absorption
    ÈíÂøÁö¼ö(ýåó·ò¦â¦).
  • infrared absorption method
    È£±â°¡½ººÐ¼®½Ã Àû¿Ü¼± Èí¼ö¹ý
  • photoelectric absorption
    ±¤ÀüÈí¼ö
  • radiofrequency absorption
    ¶óµð¿ÀÆÄ Èí¼ö
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • atomic absorption spectroscopy
    ¿øÀÚÈí±¤ ºÐ±¤ºÐ¼®¹ý(¡­ÝÂÎÃÝÂà°Ûö).
  • carbon dioxide absorption technic
    ź»ê°¡½ºÈí¼ö¹ý(¡­ýåâ¥Ûö).
  • circle absorption system
    ¼øÈ¯Èí¼ö½Ä.
  • cross absorption
    ±³Â÷Èí¼ö½ÃÇè
  • disaccharide absorption
    ÀÌź´çÈí¼ö
  • excremental absorption
    ¹è¼³¹°Èí¼ö (ÊÙÌ·Ëà).
  • fluorescent treponemal antibody absorption test
    ¸Åµ¶Çü±¤Ç×ü Èí¼ö°Ë»ç¹ý
  • folic acid absorption
    ¿±»êÈí¼ö.
  • heat absorption
    ¿­Èí¼ö(æðýåâ¥).
  • index of absorption
    ÈíÂøÁö¼ö(ýåó·ò¦â¦).
  • index of absorption
    ÈíÂøÁö¼ö(̷̤̤Ëà).
  • infrared absorption method
    È£±â°¡½ººÐ¼®½Ã Àû¿Ü¼± Èí¼ö¹ý
  • internal absorption
    ³»ºÎÈí¼ö(¡­ýåâ¥).
  • lacuna absorption
    Èí¼ö¼Ò¿Í.
  • maximum absorption
    ÃÖ´ëÈí¼ö.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • energy sink
    ¿¡³ÊÁö ½ÌÅ©
  • energy transduction
    ¿¡³ÊÁö Àüȯ(ï®üµ)
  • energy transfer
    ¿¡³ÊÁö ÀüÀÌ(ï®ì¹)
  • energy well
    ¿¡³ÊÁö ¿ì¹°
  • free energy
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö
  • free energy change
    ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö º¯È­(ܨûù)
  • Gibbs free energy
    ±é½º ÀÚÀ¯(í»ë¦)¿¡³ÊÁö
  • Helmholtz free energy
    Ç︧ȦÃ÷ ÀÚÀ¯(í»ë¦) ¿¡³ÊÁö
  • high-energy bond
    °í(ÍÔ)¿¡³ÊÁö °áÇÕ(Ì¿ùê)
  • high-energy compound
    °í(ÍÔ)¿¡³ÊÁö È­ÇÕ¹°(ûùùêÚª)
  • high-energy ion scattering
    °í(ÍÔ)¿¡³ÊÁö À̿»ê¶õ(ߤկ)
  • high-energy phosphate donor
    °í(ÍÔ)¿¡³ÊÁö ÀÎ»ê°ø¿©ÀÚ(×òß«Íêæ¨í­)
  • internal energy
    ³»ºÎ(Үݻ)¿¡³ÊÁö
  • ionization energy
    ÀÌ¿ÂÈ­(ûù) ¿¡³ÊÁö
  • ionizing energy
    ÀÌ¿ÂÈ­(ûù) ¿¡³ÊÁö
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ANAP agglutination negative, absorption positive [reaction]
CA anterior commissure [Lat. commissura anterior]; calcium antagonist; California [rabbit]; cancer; Can...
CCAT chick cell agglutination test; conglutinating complement absorption test
DAR death after resuscitation; diacereine; differential absorption ratio
DOA date of admission; dead on arrival; Department of Agriculture; depth of anesthesia; differential opt...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
FTA-ABS Fluorescent Treponema Antibody-Absorption test
FTA-ABS Fluorescent Treponemal Antibody Absorption
GF-AAS Graphite furnace atomic absorption spectrometry
HG-AAS Hydride-generation atomic absorption spectrometry
SAR Specific Absorption Rate
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • bound energy
    °áÇÕ ¿¡³ÊÁö
  • catabolism of energy
    ¿¡³ÊÁöÀÇ ÀÌÈ­ ´ë»ç
    »ì¾Æ ÀÖ´Â Á¶Á÷¿¡¼­ ÀÛ¾÷À̳ª ¿­·Î ¿¡³ÊÁö°¡ ¹ß»êµÇ´Â °Í. ÇÑ ´Ü°è´Â ´ë»ç ÀÛ¿ëÀ̰í, ÇÑ ´Ü°è´Â ÀÌÈ­ ´ë»çÀÌ´Ù.
  • dual energy
    ÀÌÁß ¿¡³ÊÁö
  • energetic exhibiting energy

    energetics

    ¿¡³ÊÁö·Ð, ¿¡³ÊÁöÇÐ
    ¿¡³ÊÁöÀÇ ¿¬±¸. ¿¡³ÊÁöÀÇ °úÇÐ.
  • energy
    ¿¡³ÊÁö
    1. ·¹ÀÌÀú¿¡ À־ ¿¡³ÊÁö´Â ½Ã°£°ú ÈûÀÌ °ö°ú °°´Ù. 2. ÀÏÀ» ÇÏ´Â ´É·Â, ¿îµ¿À» ÀÏÀ¸ÄѼ­ ÀúÇ×À» ±Øº¹ÇÏ¿© ¹°¸®Àû º¯È­¸¦ ÀÏÀ¸Å°´Â Èû.
  • energy charge
    ¿¡³ÊÁö ºÎÇÏ
  • energy dependency
    ¿¡³ÊÁö ÀÇÁ¸¼º
  • energy flux density
    ¿¡³ÊÁö¼Ó ¹Ðµµ
  • energy imparted
    ºÎ¿© ¿¡³ÊÁö
  • energy loss
    ¿¡³ÊÁö ¼Õ½Ç
  • energy metabolism
    ¿¡³ÊÁö ´ë»ç
  • energy parasite
    ¿¡³ÊÁö ±â»ýü
  • energy quotient
    ¿¡³ÊÁö À²
  • energy source
    ¿¡³ÊÁö ¿ø
  • high energy phosphate bond
    °í¿¡³ÊÁö ÀÎ»ê °áÇÕ
    ÀÎ»ê °áÇÕ ÇüŰ¡ ³ôÀº ¿¡³ÊÁö·Î ÀÌ·ç¾îÁø »óÅÂ. ÀÌ °áÇÕÀº ¾Æ³×³ë½Å »ïÀλê. Æ÷½ºÆ÷Å©·¹¾ÆÆ¾. ´ç ´ë»çÀÇ Áß°£»ê¹° µî¿¡ Á¸ÀçÇÑ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
external absorption The absorption of substances through skin, mucocutaneous surfaces, or mucous membranes.
(05 Mar 2000)
fluorescent treponemal antibody-absorption test <investigation> A sensitive and specific serologic test for syphilis. It is more specific than the VDRL assay.
The patient's serum is diluted to remove non-specific antibodies and then mixed on a glass slide with Nichol's strain of Treponema pallidum. If antibodies are present in the patient's serum they bind to the antigen and the bound antibodies are detected with fluoresceinated antihuman gamma-globulin antibody.
Synonym: FTA-ABS test.
(12 Sep2002)
linear absorption coefficient That fraction of ionizing radiation absorbed in a unit thickness of a substance or tissue.
See: absorption coefficient.
(05 Mar 2000)
activation energy <chemistry> The amount of energy (expressed in joules) that is needed to convert all the molecules in one mole of a reacting substance from a ground state to the transition state.
(06 May 1997)
binding energy <chemistry, radiobiology> The binding energy of a nucleus is the minimum energy required to dissociate it into its component neutrons and protons. Neutron or proton binding energies are those required to remove a neutron or proton, respectively, from a nucleus. Electron binding energy is that required to remove an electron from an atom or a molecule.
(16 Dec 1997)
bioelectric energy sources Implantable devices which convert biological energy (chemical energy of the metabolism of continuously regenerating body fluids or mechanical energy of periodic movements) to electrical energy. The sources include biogalvanic cells, biofuel cells, and ionic concentration cells.
(12 Dec 1998)
biomass energy See Bioenergy.
(05 Dec 1998)
bond dissociation energy This is the energy needed to break the bonds between two linked atoms.
(09 Oct 1997)
bond energy The energy needed to break a molecular bond.
(09 Oct 1997)
radiography, dual-energy scanned projection A method of producing a high-quality scan by digitizing and subtracting the images produced by high- and low-energy X-rays.
(12 Dec 1998)
radiotherapy, high-energy Radiotherapy using high-energy (megavolt or higher) ionizing radiation. Types of radiation include gamma rays, produced by a radioisotope within a teletherapy unit; X-rays, electrons, protons, alpha particles (helium ions) and heavy charged ions, produced by particle acceleration; and neutrons and pi-mesons (pions), produced as secondary particles following bombardment of a target with a primary particle.
(12 Dec 1998)
Parallel Electron Energy Loss Spectroscopy <technique> Electron energy loss spectroscopy analyses the inelastically scattered electrons present in the beam after it has been transmitted through the sample. An electron energy loss spectrum typically consists of a monatomic decreasing background on which are superimposed a number of peaks. Each peak is characteristic of the scattering process that has occurred in the sample. The peaks can be used to obtain information about the chemical composition and electronic structure of the sample. Electron energy loss spectra are acquired typically in a magnetic sector spectrometer located under the camera chamber of the transmission electron microscope. Spatial resolution is typically limited by the minimum probe diameter of the microscope. Electron energy loss spectroscopy tends to be complimentary to EDS in that it can be used to analyse very thin samples of low Z materials.
Acronym: PEELS
(05 Aug 1998)
geothermal energy Energy derived from the natural heat of the Earth contained in hot rocks, hot water, hot brines or steam.
(05 Dec 1998)
Gibbs energy of activation The Gibbs energy that must be added to that already possessed by a molecule or molecules in order to initiate a reaction.
(05 Mar 2000)
gibbs free energy The total amount of energy which is either used up or released during a chemical reaction. Gibbs free energy (delta G) = (delta H) - t (delta s): where (delta H) is the change in enthalpy, calculated by adding up the amount of energy released or used up to break or form chemical bonds during the reaction, t is the temperature at which the reaction took place, and (delta S) is the change in entropy, or amount of disorder, that occurs in the molecules involved during the reaction.
(09 Oct 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á